Trials / Terminated
TerminatedNCT05238077
Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo
Comparing the Efficacy of VL-UVA1 Versus NB-UVB on Inducing Repigmentation in Subjects With Generalized Vitiligo
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
As part of this study, you may have a procedure called phototherapy which involves either VL-UVA or NB-UVB irradiation. NB-UVB phototherapy is not experimental in vitiligo, but use of VL-UVA1 phototherapy in vitiligo is. The purpose of this pilot study is to determine whether VL-UVA1 or NB-UVB phototherapy more efficiently induces repigmentation in patients with generalized vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy | Patients will have different kinds of light shined on different areas |
Timeline
- Start date
- 2018-02-26
- Primary completion
- 2020-05-01
- Completion
- 2020-06-02
- First posted
- 2022-02-14
- Last updated
- 2022-02-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05238077. Inclusion in this directory is not an endorsement.